Interestingly, Kaplan-Meier analysis revealed that SLC16A1/SLC16AS-AS1 co-expression is significantly associated with patient survival not only in BC but also across several other cancer types as evidenced in Pan Cancer cohorts (Figure 1I). This evidence concerns the gene SLC16A1 and breast cancer.